.png?width=500&height=162&name=Generis%20Logo%20(2).png "Generis Logo (2)")
Recent Posts
Many biopharmaceutical manufacturers are Implementing single-use containment and transfer of media and buffer materials...
Protein-based therapeutics, specifically monoclonal antibodies (mAbs), have become the focus of pharmaceutical R&D over...
This article first appeared in BioPharm International, October 1, Caroline Hroncich
Single use powder containment practices are still in their infancy but keeping your product from cross contamination...
You know that tomorrow’s medicine is personalized. With more than 8,100 active cell therapy studies and 1,300 active...
At the American Biomanufacturing Summit last May we had the opportunity to sit down with one of our key speakers,...
eBook: Q&A with Brandon Varnau, Vice President and Head of Operations Quality, Sanofi Specialty Care
Our next eBook features industry insights and forecasts from Brandon Varnau, Vice President and Head of Operations...
Operational excellence is a key area of focus at the American Biomanufacturing Summit taking place on May 10-11 in San...
We were thrilled that Robert Sparadoski, Associate Vice President, Quality Assurance at Ferring Pharmaceuticals could...
There are many changes on the horizon for the life sciences industry. To help pharmaceutical manufacturers navigate the...